therascreen EGFR RGQ PCR Kit (24), Reference Number REF 870121
Published June 17, 2020 · Recall initiated: April 8, 2020
Summary
FDA records medical device Class II recall Z-2290-2020, published June 17, 2020 and initiated April 8, 2020. Recalling firm: Qiagen Sciences LLC; Status: Terminated; Reported quantity: 530 kits within expiry; Lot: All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There is a risk for a false mutation positive result in rare cases resulting from a fluorescence artefact. In these rare cases, the controls pass correctly, while a fluorescence artefact in the mutation assay causes an incorrect valid mutation positive result.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Qiagen Sciences LLC
- Distributor
- US Nationwide.
- Lot
- All lots
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAQIAcube Connect MDx - IVD Instrument designed to perform automated isolation and purification of nucleic acidsJuly 24, 2024
- FDAEZ2 Connect MDx-IVD Designed to perform automated isolation and purification of nucleic acids in molecularApril 17, 2024
- FDAQIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223January 12, 2022
- FDAElekta Unity, UDI 05060191071321, Image-guided radiation therapy system - Product Usage: is indicated forJune 17, 2020
- FDAFilmArray BCID Panel, RFIT-ASY-0126, 30, Rx Only, CE, IVD, UDI: 00815381020086 used with the followingJune 17, 2020
- FDAQIAsymphony SP SOW 5.0.3, software used with the QIAsymphony SP Instrument (The QIAsymphony SP instrument isAugust 28, 2019
Questions about this recall
Was therascreen EGFR RGQ PCR Kit (24), Reference Number REF 870121 recalled?
Yes. FDA published recall Z-2290-2020 on June 17, 2020. Reported hazard: There is a risk for a false mutation positive result in rare cases resulting from a fluorescence artefact. In these rare cases, the controls pass correctly, while a fluorescence artefact in the mutation assay causes an incorrect valid mutation positive result.
What should I do if I have this product?
Voluntary: Firm initiated · Letter